Pilot Study: Mindfulness-Based Cognitive Therapy as a Tool for Prophylactic Mood Stabilizing Therapy in Bipolar Disorder
NCT ID: NCT00999765
Last Updated: 2023-05-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
36 participants
OBSERVATIONAL
2008-06-30
2012-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Mindfulness-Based Cognitive Behavior Therapy for Bipolar Disorder
NCT01126827
Mindfulness Based Cognitive Therapy for Bipolar Disorder
NCT03507647
"Mindfulness vs Psychoeducation in Bipolar Disorder"
NCT02133170
Maintenance Therapies in Bipolar Disorders
NCT00000369
Evaluating the Effectiveness of Family-Focused Psychoeducation in Treating Adolescents With Bipolar Disorder
NCT00571402
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Bipolar Disorder - stable
Mindfulness-Based Cognitive Therapy
eight-week (two hours a week) group therapy (8-12 patients per group)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Mindfulness-Based Cognitive Therapy
eight-week (two hours a week) group therapy (8-12 patients per group)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Bipolar disorder (as per the Structured Clinical Interview for DSM Disorders (SCID)(22)), euthymic state: Complete remission for at least four weeks ((Montgomery and Asberg Rating Scale (MADRS) ≤ 6 and item-1 (depressed mood) = 0 and no suicidal ideations (MADRS(item-10) \< 4)
* Must have had at least 3 depressive phases in the last 5 years
* Cooperative and willing to complete all the aspects of the study and especially the 45 minutes of exercise per day
* Must have completed a Secondary V (11th grade) education
Exclusion Criteria
* Rapid cycling
* Bipolar disorder secondary to a medical condition or substance-induced mood disorder
* Suicidal ideations (MADRS(item 10)\>3)
* Active i.e. unstable and/or untreated medical condition
* Substance abuse (defined as per DSM-IV) in the last four weeks
* CBT (No more than four sessions (ever))
* Previous participation in a psychoeducation group within the last 6 months
* Current other psychotherapy (more than once a month)
* Practice of meditation (more than once a month) during the last two years
* Practice of yoga (more than once a week) during the last year
* Previous participation in a MBSR group
* Electroconvulsive Therapy (ECT) within the last three months
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Douglas Mental Health University Institute
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Serge Beaulieu
Serge Beaulieu
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Serge Beaulieu, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
Douglas Mental Health University Institute / McGill
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Douglas Mental Health University Institute
Montreal, Quebec, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
BD-MBCT
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.